Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review

摘要

Introduction: Enterococci have become the second leading cause of nosocomial infections in the U.S, which are associated with higher morbidity, mortality, length of stay, and cost due to escalating resistance to several antimicrobial agents. With limited treatment options, the adverse events associated with the increasing use of available agents must be considered.